Influence of Concurrent Capecitabine Based Chemoradiotherapy with Bevacizumab on The Survival Rate, Late Toxicity and Health-related Quality of Life in Locally Advanced Rectal Cancer: a Prospective Phase II CRAB Trial

BACKGROUND: Few studies reported early results on efficacy, toxicity of combined modality treatment for locally advanced rectal cancer (LARC) by adding bevacizumab to preoperative chemoradiotherapy, but long-term data on survival, and late complications are lacking. Further, none of the studies repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Velenik, Vaneja, Zadnik, Vesna, Omejc, Mirko, Grosek, Jan, Tuta, Mojca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585344/
https://www.ncbi.nlm.nih.gov/pubmed/32738130
http://dx.doi.org/10.2478/raon-2020-0043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585344/
https://www.ncbi.nlm.nih.gov/pubmed/32738130
http://dx.doi.org/10.2478/raon-2020-0043

Ejemplares similares